Christopher G. Hayes - 09 Oct 2024 Form 4 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VRCA	Employee Stock Option (right to buy)	Award	$0	+50,000		$0.000000	50,000	09 Oct 2024	Common Stock	50,000	$1.28	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	50% of the total shares subject to the option shall vest on each of April 9, 2025 and October 9, 2025, subject to the Reporting Person's continuous service through such vesting date.